Tag: Spiriva
-
Spiriva Respimat Now Available in Pharmacies for Asthma Patients – Pharmacy Times
Spiriva Respimat Now Available in Pharmacies for Asthma PatientsPharmacy Times“Despite taking other daily maintenance treatments, many people with asthma continue to experience symptoms, including coughing, wheezing, and shortness of breath,” said Michael Foggs, chief of allergy and immunology for the Advocate Medical Group at …and more » View full post on asthma – Google News
-
New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US – Lung Disease News
Lung Disease News New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in USLung Disease NewsBoehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food and Drug …SPIRIVA® RESPIMAT® Now Available in the US for…
-
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents – Business Wire (press release)
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and AdolescentsBusiness Wire (press release)INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a …and more » View full post on asthma…
-
SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents – Business Wire (press release)
SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and AdolescentsBusiness Wire (press release)INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a …SPIRIVA RESPIMAT Now Available in…
-
SPIRIVA RESPIMAT Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents – PR Newswire (press release)
SPIRIVA RESPIMAT Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and AdolescentsPR Newswire (press release)RIDGEFIELD, Conn., Feb. 3, 2016 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced that SPIRIVA RESPIMAT is now available by prescription for the treatment of asthma in U.S. pharmacies. The U.S. Food and Drug …and more » View full…
-
Spiriva Respimat Now Approved for Asthma – Pharmacy Times
Spiriva Respimat Now Approved for AsthmaPharmacy TimesThe FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat). This long-acting muscarinic antagonist (LAMA) was originally approved in September 2014 for the maintenance treatment of chronic …FDA approves Spiriva Respimat for asthma in adults, adolescentsHealioall 2 news articles » View full post on asthma…
-
FDA approves Spiriva Respimat for asthma in adults, adolescents – Healio
FDA approves Spiriva Respimat for asthma in adults, adolescentsHealio“The [FDA] approval of Spiriva Respimat in asthma establishes a new class of inhaled asthma therapy and provides an efficacious, new option for patients,” William Mezzanotte, MD, MPH, said in the release. “There is extensive clinical evidence … View full post on asthma – Google News
-
Spiriva Respimat (Tiotropium) Gets Asthma Indication in US – Medscape
European Pharmaceutical Review Spiriva Respimat (Tiotropium) Gets Asthma Indication in USMedscapeThe US Food and Drug Administration (FDA) has approved the long-acting muscarinic antagonist tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for long-term maintenance treatment of asthma in people aged 12 years and older, according to a …FDA approves Boehringer's asthma treatmentWestfair OnlineFDA approves asthma treatment Spiriva RespimatEuropean…
-
FDA to review new drug application for Spiriva Respimat for asthma – Healio
FDA to review new drug application for Spiriva Respimat for asthmaHealioBoehringer Ingelheim Pharmaceuticals announced that the FDA has agreed to review its new drug application for tiotropium bromide inhalation spray for long-term maintenance of patients aged 12 years and older with asthma, according to a press release.Boehringer Ingelheim Announces U.S. Filing Acceptance of New Drug…
-
Spiriva Cuts Flares in Heavily Treated Asthma – MedPage Today
Spiriva Cuts Flares in Heavily Treated AsthmaMedPage TodaySAN DIEGO — Tiotropium (Spiriva) Respimat improved lung function and cut exacerbations in severe asthma patients who had already maxed out other treatment options, pooled analysis of two phase III trials showed. Tiotropium cut severe exacerbations … View full post on asthma – Google News